La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Shanghai Haohai Biological Technology Gestione
Gestione criteri di controllo 4/4
Shanghai Haohai Biological Technology's Il CEO è Jianying Wu, nominato in Jul2010, ha un mandato di 14.08 anni. possiede direttamente 4.76% delle azioni della società, per un valore di HK$ 658.30M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 9.7 anni e 10.8 anni.
Informazioni chiave
Jianying Wu
Amministratore delegato
CN¥1.9m
Compenso totale
| Percentuale dello stipendio del CEO | n/a |
| Mandato del CEO | 14.1yrs |
| Proprietà del CEO | 4.8% |
| Durata media del management | 9.7yrs |
| Durata media del Consiglio di amministrazione | 10.8yrs |
Aggiornamenti recenti sulla gestione
Recent updates
We Think Shanghai Haohai Biological Technology (HKG:6826) Can Manage Its Debt With Ease
Jul 25
Why We Think Shanghai Haohai Biological Technology Co., Ltd.'s (HKG:6826) CEO Compensation Is Not Excessive At All
May 22Shanghai Haohai Biological Technology (HKG:6826) Seems To Use Debt Rather Sparingly
Apr 17Are Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Investors Paying Above The Intrinsic Value?
Feb 12Is Shanghai Haohai Biological Technology (HKG:6826) Using Too Much Debt?
Nov 14Shanghai Haohai Biological Technology (HKG:6826) Has A Pretty Healthy Balance Sheet
Jul 28We Think Shanghai Haohai Biological Technology (HKG:6826) Can Stay On Top Of Its Debt
Mar 09These 4 Measures Indicate That Shanghai Haohai Biological Technology (HKG:6826) Is Using Debt Reasonably Well
Nov 25Shanghai Haohai Biological Technology (HKG:6826) Has A Pretty Healthy Balance Sheet
Jul 30Shanghai Haohai Biological Technology Co., Ltd.'s (HKG:6826) Intrinsic Value Is Potentially 96% Above Its Share Price
May 08Is Shanghai Haohai Biological Technology (HKG:6826) Using Too Much Debt?
Apr 19Analyst Forecasts Just Became More Bearish On Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)
Mar 04Shanghai Haohai Biological Technology Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Mar 03Is Shanghai Haohai Biological Technology (HKG:6826) A Risky Investment?
Jan 10Shanghai Haohai Biological Technology (HKG:6826) Seems To Use Debt Rather Sparingly
Oct 08Here's Why Shanghai Haohai Biological Technology (HKG:6826) Can Manage Its Debt Responsibly
Jul 07Analysts Have Just Cut Their Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Revenue Estimates By 14%
May 27These 4 Measures Indicate That Shanghai Haohai Biological Technology (HKG:6826) Is Using Debt Reasonably Well
Apr 04Investors Who Bought Shanghai Haohai Biological Technology (HKG:6826) Shares A Year Ago Are Now Up 58%
Mar 16Can Mixed Fundamentals Have A Negative Impact on Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Current Share Price Momentum?
Feb 23What Type Of Shareholders Own The Most Number of Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Shares?
Feb 05
Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | CN¥432m |
| Dec 31 2023 | CN¥2m | n/a | CN¥416m |
| Sep 30 2023 | n/a | n/a | CN¥346m |
| Jun 30 2023 | n/a | n/a | CN¥315m |
| Mar 31 2023 | n/a | n/a | CN¥226m |
| Dec 31 2022 | CN¥2m | CN¥855k | CN¥180m |
| Sep 30 2022 | n/a | n/a | CN¥203m |
| Jun 30 2022 | n/a | n/a | CN¥192m |
| Mar 31 2022 | n/a | n/a | CN¥272m |
| Dec 31 2021 | CN¥1m | CN¥845k | CN¥352m |
| Sep 30 2021 | n/a | n/a | CN¥428m |
| Jun 30 2021 | n/a | n/a | CN¥434m |
| Mar 31 2021 | n/a | n/a | CN¥370m |
| Dec 31 2020 | CN¥1m | CN¥768k | CN¥230m |
| Sep 30 2020 | n/a | n/a | CN¥232m |
| Jun 30 2020 | n/a | n/a | CN¥216m |
| Mar 31 2020 | n/a | n/a | CN¥279m |
| Dec 31 2019 | CN¥2m | CN¥742k | CN¥371m |
| Sep 30 2019 | n/a | n/a | CN¥353m |
| Jun 30 2019 | n/a | n/a | CN¥386m |
| Mar 31 2019 | n/a | n/a | CN¥375m |
| Dec 31 2018 | CN¥1m | CN¥712k | CN¥415m |
| Sep 30 2018 | n/a | n/a | CN¥411m |
| Jun 30 2018 | n/a | n/a | CN¥408m |
| Mar 31 2018 | n/a | n/a | CN¥390m |
| Dec 31 2017 | CN¥1m | CN¥583k | CN¥372m |
Compensazione vs Mercato: La retribuzione totale di Jianying ($USD 267.02K ) è inferiore alla media delle aziende di dimensioni simili nel mercato Hong Kong ($USD 588.16K ).
Compensazione vs guadagni: La retribuzione di Jianying è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Jianying Wu (60 yo)
14.1yrs
Mandato
CN¥1,904,800
Compensazione
Dr. Jianying Wu has been General Manager of Shanghai Haohai Biological Technology Co., Ltd. since July 23, 2010 and has been its Executive Director since December 2014. Mr. Wu served as a Director at Shang...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Executive Chairman | 14.1yrs | CN¥1.89m | 4.73% CN¥ 654.2m | |
| GM & Executive Director | 14.1yrs | CN¥1.90m | 4.76% CN¥ 658.3m | |
| CFO & Executive Director | 7.7yrs | CN¥1.45m | 0.047% CN¥ 6.5m | |
| Executive Director | 9.7yrs | CN¥1.26m | 0.35% CN¥ 48.7m | |
| Joint Company Secretary | 4.7yrs | CN¥868.70k | 0.0080% CN¥ 1.1m | |
| Deputy General Manager | 9.9yrs | CN¥912.50k | 0.021% CN¥ 3.0m | |
| Joint Company Secretary | 9.8yrs | Nessun dato | Nessun dato |
9.7yrs
Durata media
49yo
Età media
Gestione esperta: Il team dirigenziale di 6826 è esperto e expertise (durata media dell'incarico 9.7 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Executive Chairman | 14.1yrs | CN¥1.89m | 4.73% CN¥ 654.2m | |
| GM & Executive Director | 14.1yrs | CN¥1.90m | 4.76% CN¥ 658.3m | |
| CFO & Executive Director | 7.5yrs | CN¥1.45m | 0.047% CN¥ 6.5m | |
| Executive Director | 14.1yrs | CN¥1.26m | 0.35% CN¥ 48.7m | |
| Independent Non-Executive Director | less than a year | Nessun dato | Nessun dato | |
| Non Executive Director | 14.1yrs | Nessun dato | 61.18% CN¥ 8.5b | |
| Non-Executive Director | 14.1yrs | CN¥150.00k | 1.57% CN¥ 217.0m | |
| Chairman of the Supervisory Committee | 14.1yrs | Nessun dato | 1.57% CN¥ 217.0m | |
| Independent Non-Executive Director | 4.2yrs | CN¥150.00k | Nessun dato | |
| Independent Non-Executive Director | 4.2yrs | CN¥150.00k | Nessun dato | |
| Independent Non-Executive Director | 4.2yrs | CN¥150.00k | Nessun dato | |
| Independent Non-Executive Director | 4.2yrs | CN¥150.00k | Nessun dato |
10.8yrs
Durata media
52.5yo
Età media
Consiglio di amministrazione esperto: Il consiglio di amministrazione di 6826 è composto da personale esperto e esperto (durata media dell'incarico 10.8 anni).